Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M402Revenue $M5.5Net Margin (%)-2,320.7Altman Z-Score2.3
Enterprise Value $M116EPS $-1.3Operating Margin %-2,363.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-2,320.7Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio9.8Cash flow > EarningsY
Price/Sales74.05-y EBITDA Growth Rate %--Current Ratio9.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.8Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-41.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M98.7ROIC % (ttm)-1,041.6Gross Margin Increase y-yN

Gurus Latest Trades with CLDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CLDXFirst Eagle Investment 2015-12-31 Add$11.45 - $18.11
($14.68)
$ 4.21-71%Add 3.57%579,542
CLDXJoel Greenblatt 2015-06-30 Sold Out -0.01%$23.67 - $30.1
($26.5)
$ 4.21-84%Sold Out0
CLDXJoel Greenblatt 2015-03-31 Buy 0.01%$18.29 - $31.78
($23.85)
$ 4.21-82%New holding35,223
CLDXFirst Eagle Investment 2014-12-31 Add0.01%$12.55 - $20.93
($16.61)
$ 4.21-75%Add 123.82%559,542
CLDXFirst Eagle Investment 2014-09-30 Buy 0.01%$12.05 - $17.57
($14.51)
$ 4.21-71%New holding250,000
CLDXFirst Eagle Investment 2014-03-31 Sold Out -0.0089%$16.95 - $31.59
($25.58)
$ 4.21-84%Sold Out0
CLDXFirst Eagle Investment 2013-12-31 Reduce-0.04%$21.51 - $36.71
($25.51)
$ 4.21-83%Reduce -75.45%135,000
CLDXFirst Eagle Investment 2013-06-30 Reduce-0.02%$11.01 - $16.09
($13.13)
$ 4.21-68%Reduce -45.89%665,560
CLDXGeorge Soros 2012-06-30 Sold Out -0.06%$3.9 - $5.26
($4.39)
$ 4.21-4%Sold Out0
CLDXFirst Eagle Investment 2012-06-30 Add0.02%$3.9 - $5.26
($4.39)
$ 4.21-4%Add 260.87%1,660,000
CLDXGeorge Soros 2012-03-31 Buy 0.06%$2.77 - $5.46
($4)
$ 4.215%New holding803,200
CLDXFirst Eagle Investment 2012-03-31 Add0.01%$2.77 - $5.46
($4)
$ 4.215%Add 360.00%460,000
CLDXFirst Eagle Investment 2011-12-31 Reduce$2.11 - $3.21
($2.7)
$ 4.2156%Reduce -71.43%100,000
CLDXFirst Eagle Investment 2011-06-30 Buy 0.01%$3.03 - $4.46
($3.75)
$ 4.2112%New holding350,000
CLDXFirst Eagle Investment 2010-03-31 Sold Out $4.35 - $6.39
($4.94)
$ 4.21-15%Sold Out0
CLDXFirst Eagle Investment 2009-12-31 Buy $4.2 - $5.66
($4.78)
$ 4.21-12%New holding100,000
CLDXFirst Eagle Investment 2009-09-30 Sold Out $4.95 - $7.93
($6.33)
$ 4.21-33%Sold Out0
CLDXFirst Eagle Investment 2009-06-30 Buy $6.81 - $11.22
($8.56)
$ 4.21-51%New holding50,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CLDX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


CLDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CATLIN AVERY WSr. VP & CFO 2015-11-23Sell25,000$18-76.61view
ELLBERGER LARRYDirector 2015-08-25Buy5,000$14-69.93view
ELLBERGER LARRYDirector 2015-08-20Buy5,000$15-71.93view
ELLBERGER LARRYDirector 2015-08-18Buy5,000$15.95-73.61view
ELLBERGER LARRYDirector 2015-08-13Buy5,000$16.59-74.62view
Marucci Anthony SPresident and CEO 2015-08-13Buy5,800$16.81-74.96view
CATLIN AVERY WSr. VP & CFO 2015-06-15Sell25,000$24.59-82.88view
van den Broek RichardDirector 2014-12-17Sell0$0-82.88view
LIPTON KAREN SHOOSDirector 2013-12-06Sell17,728$24.5-82.82view
PENNER HARRY JRDirector 2013-12-06Sell17,728$24.5-82.82view

Quarterly/Annual Reports about CLDX:

News about CLDX:

Articles On GuruFocus.com
Cantor Fitzgerald and Brean Capital Positive on Celldex Therapeutics Following Positive Data For Bra Jun 01 2015 
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Roth Capital Weighs In On 5 Biotech Stocks to Watch Apr 05 2015 
Cowen & Co Remains Bullish on Celldex Therapeutics Following FDA 'Breakthrough' Approval Feb 24 2015 
CLDX up 223%, Cohen Gains Big Apr 23 2013 
Steve Cohen Increases Celldex Up 145% Apr 06 2013 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 
CELLDEX THERAPEUTICS, INC (CLDX) CEO Anthony S Marucci buys 12,000 Shares Sep 13 2010 
Weekly CFO Buys Highlight: GNMK, RTIX, BKOR, PTEK, CLDX Sep 12 2010 
CELLDEX THERAPEUTICS, INC Reports Operating Results (10-Q) Aug 05 2010 

More From Other Websites
Biotech Stocks Earnings Preview: REGN, LGND, ECYT & More May 03 2016
Celldex (CLDX): What's Ahead for the Stock in Q1 Earnings? May 02 2016
Celldex Therapeutics Initiates Phase 1/2 Study of Glembatumumab Vedotin in Squamous Cell Lung Cancer Apr 27 2016
Celldex Therapeutics Initiates Phase 1/2 Study of Glembatumumab Vedotin in Squamous Cell Lung Cancer Apr 27 2016
4 Biotech Stocks to Buy at Beaten Down Prices Apr 26 2016
Get The Jump On Next Week With These 4 Trending Small Cap Stocks Apr 22 2016
This Biotech Is Up 300% In Two Months Apr 20 2016
Celldex Therapeutics Presents Data Supporting the Clinical Development of Glembatumumab Vedotin and... Apr 20 2016
Celldex Therapeutics Presents Data Supporting the Clinical Development of Glembatumumab Vedotin and... Apr 20 2016
Celldex Therapeutics Presents Favorable Safety Profile and Immune Response Data from Phase 1/2 Study... Apr 18 2016
Celldex Therapeutics Presents Favorable Safety Profile and Immune Response Data from Phase 1/2 Study... Apr 18 2016
4 Small Cap Stocks That Have To Be On Your Watchlist Today Apr 14 2016
Six Technologies That Will Change Healthcare Apr 07 2016
iShares Nasdaq Biotechnology ETF (IBB) Had Strong Start to April Apr 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)